In Brief
Influenza infection causes mortality in infants and protective immunity in this population is poorly understood. Guo et al. find that gd T cells are required for recovery after neonatal influenza infection. gd T cell-derived IL-17A is associated with the tissue repair response orchestrated by IL-33, ILC2s, and amphiregulin, and IL-17A correlates with improved disease outcomes in influenza-infected children.
INTRODUCTION
Influenza viruses are among the most common and significant pathogens that underlie human respiratory diseases, with high morbidity and mortality (Taubenberger and Kash, 2010; Taubenberger and Morens, 2008) . These viruses primarily infect respiratory epithelial cells where, after detection by immune sensors, the host will initiate innate and adaptive immune responses that guide viral clearance and tissue repair (Dash and Thomas, 2014; Iwasaki and Pillai, 2014) . Whereas viral clearance is primarily promoted by type 1 immune responses through effector
CD8
+ T cells (Cerwenka et al., 1999; Duan and Thomas, 2016; Duan et al., 2015) , group 2 innate lymphoid cells (ILC2s) regulated by interleukin (IL)-33-IL-33R signaling promote type 2 immune responses and are important for lung homeostasis and repair following influenza infection (Chang et al., 2011; Gorski et al., 2013; Guo and Thomas, 2017; Le Goffic et al., 2011; Monticelli et al., 2011) . Similarly, regulatory T (Treg) cells and T helper (Th) cells have been implicated in beneficial influenza immune responses mediated by IL-33-driven tissue restoration via production of amphiregulin (Areg) (Arpaia et al., 2015) . Although the downstream immune responses and tissue repair process induced by IL-33 have been well defined, the production and upstream regulation of IL-33 is still unclear. Compared to adults, infants suffer relatively higher rates of hospitalization, severe clinical complications, and mortality as a result of influenza infection (Bhat et al., 2005; Munoz, 2003) . The proximate mechanisms guiding these age-dependent differences may also be related to exaggerated type 2 responses that are characteristic of the infant immune system (Adkins et al., 2004; Dowling and Levy, 2014; Garcia et al., 2000; de Kleer et al., 2016) , mediated by the IL-33 pathway (de Kleer et al., 2016; Saluzzo et al., 2017) , and may function to prevent tissue damage owed to excessive inflammation. Thus, the pathologies concomitant with influenza infection, and their respective therapeutic targets, likely differ between infants and adults. In adult influenza infection, CD8 + T cells predominate the antiviral response (Cerwenka et al., 1999; Duan and Thomas, 2016; Duan et al., 2015) , but in infant influenza infection, CD8 + T cells exhibit relatively reduced functionality (You et al., 2008) . In contrast to CD8 + T cells, gd T cells are the first T cells to appear in the thymus during fetal development and have the capacity to recognize a wide range of antigens and respond rapidly to infections (Chien et al., 2014; Vantourout and Hayday, 2013) even during infancy; for instance, these cells are known to play important roles in the infant immune response to RSV infection (Huang et al., 2015) and enterocolitis (Weitkamp et al., 2014) . The IL-17A producers, in particular, are known to play a prominent role in lung immunity to bacterial infections, where rapid IL-17A production is critical for the recruitment of protective neutrophil responses (Romagnoli et al., 2016) . For the most part, gd T cells have not been associated with inducing type 2 immune effectors. Although gd T cells may likewise act as immune sentinels during neonatal influenza infection, the functions of gd T cells in influenza-infected infants remain to be elucidated.
In this study, utilizing a neonatal mouse model of influenza infection, we report that gd T cells played an important role in protecting suckling mice against viral infection. This protection was mediated by augmentation of IL-33 production from the mucosal compartment that was induced by IL-17A secreted from the responding gd T cells. We further showed that this IL-17A-dependent IL-33 production subsequently generates a local type 2 immune response with increased accumulation of Aregproducing ILC2s and Treg cells in the lung, thus promoting tissue repair and lung integrity after infection. We also observed correlations between IL-17A, IL-33, and Areg in nasal washes of human influenza-infected infants. Thus, our findings reveal important roles for gd T cells in directing an axis of IL-17A and IL-33 production, promoting tissue recovery after infection, and providing a potential therapeutic target.
RESULTS

gd T Cells Protect Neonatal Mice against Influenza Infection by Promoting Tissue Restoration Independent of Viral Clearance
In influenza-infected adult mice, cytotoxic CD8 + T cells can express death receptors and produce cytokines and lytic mediators that promote viral clearance (Brincks et al., 2008; La Gruta and Turner, 2014; Moskophidis and Kioussis, 1998) . However, during infancy the immune system remains developmentally immature, with relatively fewer and less diverse CD8 + T cells compared to adults (You et al., 2008) . In contrast, many gd T cell subsets develop fetally and thus are available to respond in neonates. To investigate whether gd T cells can respond to neonatal influenza infection, we infected 7-day-old wild-type neonates with A/HKx31 (H3N2) influenza virus. After infection, we observed a significant accumulation of gd T cells, characterized by increases in both frequency and cell number ( Figure 1A ) although there was no change in mock-infected lungs of the same age ( Figure S1 ). EdU (5-ethynyl-2 0 -deoxyuridine) cell incorporation assays indicated that the increases in gd T cells in infected lungs were at least partially due to gd T cell proliferation ( Figure 1B) . In order to understand the function of gd T cells during influenza infection, we next infected a neonatal cohort of wild-type and gd T cell receptor-deficient (Tcrd À/À ) animals with influenza virus. Compared to Tcrd À/À mice, relative weight gains were overall significantly larger in wild-type neonates (Figure 1C) . Wild-type neonates also had a significantly increased survival rate compared to Tcrd À/À mice ( Figure 1D ), yet the two groups demonstrated no detectable difference in tissue viral clearance at any time point after infection ( Figure 1E ). Consistent with the viral titer, loss of gd T cells did not alter the levels of IFN-g at day 7 after infection ( Figure 1F ). Figure 1G ). Several pathways relevant to tissue development and regeneration were enriched in wild-type lungs, including the epithelial growth factor receptor (EGFR) pathway (Hall et al., 2016; Monticelli et al., 2011; Zaiss et al., 2015) and the hedgehog pathway (Hogan et al., 2014; Sriperumbudur et al., 2017) . The absence of gd T cells was associated with increased inflammatory pathways, including TNF-a, IL-6, and IL-5. In order to investigate the downstream effects of these gd T cell-mediated immune responses on infected lungs, we performed H&E staining of lung sections. At 15 days after infection, Tcrd À/À mice were characterized by increased perivascular and interstitial inflammation and bronchiolar hyperplasia and metaplasia ( Figures 1H and 1I ), suggesting that gd lungs of wild-type neonates 2 days after infection. Data are combined from three independent experiments and shown as mean ± SEM. (C and D) Body weight profile (% of original weight) (C) and survival rate (D) of wild-type (black, n = 28) and Tcrd À/À (red, n = 26) neonates after influenza infection.
Data are combined from 16 independent experiments, and weight data are shown as mean ± SEM. (E) Viral titer (Log 10 TCID 50 /mL) of wild-type (black) and Tcrd À/À (red) neonates assessed by plaque assay at days 0, 3, 5, 7, and 10 after influenza infection.
Samples are pooled from at least two independent experiments for each time point and data are presented as mean ± SEM. (F) Measurement of IFN-g in the total lung homogenates by ELISA of wild-type (black, n = 5) and Tcrd À/À (red, n = 5) neonates at 7 days after influenza infection.
Samples are pooled from three independent experiments, and data are presented as mean ± SEM. (I) Summary of histological analysis from influenza-infected wild-type (black, n = 8) and Tcrd À/À (red, n = 6) lungs at 15 days after infection.
(H and I) Data are combined from two independent experiments and shown as mean ± SEM. *p < 0.05, **p < 0.01, ****p < 0.0001, n.s., not significant.
T cell deficiency disrupted lung homeostasis and tissue repair. Collectively, these data indicate that gd T cells expand after influenza infection and provide protection to infants by promoting tissue restoration rather than by enhancing the antiviral response.
gd T Cells Rapidly Produce IL-17A after Neonatal Influenza Infection To determine the mechanism by which gd T cells promoted protection in neonatal animals, we examined their phenotypes after infection by using CD27 and CD44 surface marker expression, which distinguish IL-17A-and IFN-g-producing gd T cells (Ribot et al., 2009) . We found that gd T cells were predominantly CD27 À CD44 hi in virus-infected neonatal lungs, corresponding to IL-17A production, while they were mainly CD27 + CD44
lo (corresponding to IFN-g production) after mock infection ( Figure 2A ). After influenza infection, lung gd T cells also had higher cell surface expression of CCR6 and Sca-1 ( Figure 2B ), consistent with the phenotype of IL-17A-producing gd T cells. To confirm the IL-17A-producing phenotype of lung gd T cells after influenza infection, we assayed Il17a gene expression using quantitative real-time PCR (qRT-PCR) in sorted gd T cells at different points. This analysis indicated that Il17a was upregulated transiently 1 day after infection ( Figure 2C ). In concordance with these qRT-PCR data, the intracellular staining of IL-17A in gd T cells showed an enhanced frequency and number of IL-17A-producing gd T cells in virus-infected lungs, whereas IFN-g-producing gd T cells were not significantly different ( Figures 2D and 2E , kinetics shown in Figures S3A and S3B ). This transient IL-17A production by gd T cells did not significantly alter neutrophil infiltration or accumulation ( Figure S3C ). gd T cells can be highly clonotypic in different tissues, especially with respect to Vg chain usage (Carding and Egan, 2002) . Given the enrichment in CD27
À gd T cells secreting IL-17A in influenza-infected neonates, we decided to investigate whether the T cell receptor repertoires were altered in cells exhibiting this phenotype. By utilizing single-cell PCR technology (Dash et al., 2011 (Dash et al., , 2015 Guo et al., 2016) , we characterized the TRGV family usage by CD27 + or CD27 À neonatal gd T cells (Kashani et al., 2015) Upon gating on IL-17A-positive cells, we also found that neonates contained elevated frequencies of gd T cells among total IL-17A-producing cells in the early stages of influenza infection. Furthermore, gd T cells became the dominant producers of IL-17A after infection ( Figure 2F ). However, the expression of IL-17A and IFN-g by gd T cells in adult mice showed a distinct pattern from that in neonates: consistent with a previous study (Crowe et al., 2009) , adult gd T cells produced additional IL-17A at a later stage of infection ( Figures S2C-S2E ). In conjunction, these data from neonates and adults suggest distinct functionality of gd T cells across ontogeny, such that neonatal gd T cells rapidly secrete and are the primary source of IL-17A in response to influenza infection.
IL-17A, Primarily Secreted by gd T Cells, Improves the Survival of Influenza-Infected Neonates by Enhancing IL-33 Production IL-17A is the canonical cytokine that regulates type 3 immunity, and its roles in adult influenza infection are still controversial. Some have suggested that IL-17A can be beneficial by modulating B cell responses (Wang et al., 2011) , whereas others have proposed that IL-17A signaling may increase immune pathology by promoting neutrophil infiltration in adults (Crowe et al., 2009) . Our data suggest that IL-17A might play a protective role in neonates because, in comparison to the lungs of virus-infected Tcrd À/À neonates, IL-17A (mainly produced by gd T cells)
is increased in wild-type lungs 1 day after influenza infection (Figure 3A) . To test this formally in our experimental model, we infected Tcrd À/À neonates concomitant with administration of a low level of recombinant mouse IL-17A, the dose for which was calculated based on the difference of lung total IL-17A between wild-type and Tcrd À/À neonates, and we monitored the survival rate. Low-dose IL-17A significantly improved the survival of gd T cell-deficient mice, indicating that the IL-17A pathway is protective in the neonatal animals ( Figure 3B ). In contrast, a high dose of IL-17A administered to infected Tcrd À/À mice was detrimental to the host ( Figure S4A ), as was a low dose of IL-17A administered to infected wild-type neonates (Figures S4B), suggesting that IL-17A fine-tunes the balance between pathogenicity and protection. In order to determine whether IL-17A specifically produced by gd T cells is critical for protection against neonatal influenza infection, we isolated gd T cells from wild-type or Il17a À/À neonatal lungs, transferred the cells to littermate Tcrd À/À neonates intranasally, and infected the recipients with influenza virus ( Figure 3C ). The weight change ( Figure 3D ) and survival rate ( Figure 3E ) profiles suggested that IL-17A production by gd T cells contributed to the protection gd T cells provide to infected neonates.
To explore which immune processes may have been disrupted by the loss of IL-17A in Tcrd À/À neonates, we next assessed the concentration of a panel of cytokines in homogenized lungs at day 2 after infection. The majority of cytokines generally associated with responses to influenza infection, including IFN-g, IL-2, IL-1b, KC, GM-CSF, and IP-10, exhibited no differences between wild-type and Tcrd À/À neonatal lungs at day 2 after infection, suggesting that traditional innate and type 1 responses are not dependent on gd T cells ( Figure S4C ). In contrast, we found that loss of gd T cells led to diminished levels of IL-33 ( Figures 3F  and S4D ). To confirm this observation, we again assayed IL-33 to determine whether gd T cell-derived IL-17A was sufficient for inducing IL-33 in gd T cell-deficient mice treated with IL-17A. Compared to virus-only controls, IL-33 levels in whole lung homogenates were elevated in response to low-dose IL-17A (Figure 3G) . These data suggest that IL-33 production is upregulated downstream of IL-17A, which is secreted by gd T cells in influenza virus-infected mice. In order to determine whether IL-33 production functions as a component of the protection provided by gd T cells and IL-17A in influenza-infected neonates, we next infected wild-type and Il33-deficient neonates with influenza virus. Il33 À/À neonates exhibited increased mortality compared to wild-type littermates ( Figure 3H ). In addition, and consistent with our IL-17A results, the administration of IL-33 also improved the survival of infected Tcrd À/À neonate littermates ( Figure 3I ). . Samples from mock-infected (n = 14) neonates were pooled from animals 1 (n = 11) and 2 (n = 10) days after mock infection. (F) Representative flow cytometric plots (left) and summary frequency plots (right) of gd TCR expression gated on total IL-17A-producing cells from mock-(n = 14) and virus-(n = 11) infected mice at 1 day after infection. (D-F) PMA/ionomycin was used for stimulation prior to intracellular staining. Data are combined from four independent experiments and presented as mean ± SEM. **p < 0.01, ***p < 0.001, ****p < 0.0001, n.s., not significant. or PBS control (red, n = 19) at the time of infection. Data are combined from six independent trials, which individually showed the same trend, and data are presented as mean ± SEM. (C) Schema outlining wild-type and Il17a À/À gd T cell transfers to Tcrd À/À neonates and subsequent infection.
(D and E) Body weight profile (D) and survival rate (E) of influenza-infected Tcrd À/À neonates receiving wild-type (black, n = 15) or Il17a À/À (red, n = 13) gd T cells intranasally or no cell transfer (gray, n = 10). Data are combined from four independent trials, which individually showed the same trend. Weight profile data are presented as mean ± SEM. (F) Protein levels of IL-33 assessed by ELISA in influenza virus-infected wild-type (black, n = 15) and Tcrd À/À (red, n = 9) lungs at 1 day after infection. Samples are pooled from three independent experiments, and data are shown as mean ± SEM. (G) Protein levels of IL-33 detected by ELISA in the lungs of Tcrd À/À neonates that had been infected with influenza virus and simultaneously treated with either a low level of rmIL-17A (green, n = 7, 100 pg/mouse) or PBS control (red, n = 6). Data were collected 1 day after infection/treatment. Samples are pooled from at least two independent experiments, and data are shown as mean ± SEM. Therefore, in neonatal mice, gd T cells are the primary source of IL-17A, which in turn is necessary for IL-33 production, which itself is protective in these animals.
IL-17A Promotes IL-33 Production in Mouse Lung Epithelial Cells in Synergy with Influenza Virus by Elevating STAT3 Phosphorylation
One study recently demonstrated that IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness in an allergic asthma model in BALB/c mice (Mizutani et al., 2014) . However, the precise relationship between IL-17A and IL-33 production remains unclear. Although IL-33 can be produced by multiple cell types, epithelial cells are thought to be the primary source in mouse lungs (Pichery et al., 2012) , and we found sorted lung epithelial cells from wild-type neonates to have the highest Il33 gene expression among other lung stromal cell types at day 2 after influenza infection ( Figure S4E ). We consequently set out to determine whether IL-17A could directly induce IL-33 production in lung epithelial cells. To test this, we stimulated a mouse lung type 1 epithelial cell line (LET1s) (Rosenberger et al., 2014) in vitro using influenza virus and recombinant mouse IL-17A (either individually or in combination). After 24 or 48 hr of treatment, the cells in each group were collected to assay IL-33 transcripts and protein with qRT-PCR and immunoblot, respectively. Quantification of the relative expression of Il33 mRNA showed that administration of either virus or IL-17A could enhance IL-33 production in LET1 cells, but the effect of the virus and IL-17A combination was especially striking (Figure 4A) . Consistent with these findings, substantial IL-33 protein was also detected after treatment with both stimuli by immunoblot ( Figure 4B ). Interestingly, IL-17A alone was more potent than virus alone in elevating IL-33 mRNA and protein expression. 
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We next examined the signaling pathways induced by influenza virus and IL-17A treatment in LET1 cells. Examination of the transcriptional binding sites in the human IL-33 promoter (ENCODE data in UCSC genome browser, build hg19) identified Signal Transducer and Activator of Transcription 3 (STAT3) as a potential regulator of Il33 transcription, so we performed a western blot assay to test whether STAT3 was activated downstream of treatment with either influenza virus or IL-17A. We found that phosphorylated-STAT3 (pSTAT3) was coordinately upregulated with IL-33 (data not shown). To confirm the role of pSTAT3 in IL-33 production, we inhibited the phosphorylation of STAT3 by co-incubating with S3I-201, a well-established small molecule inhibitor that prevents the dimerization and phosphorylation of STAT3 (Siddiquee et al., 2007) . Under the same stimulation conditions as above, we compared the relative expression levels of Il33 among IL-17A-and/or virus-stimulated LET1 cells that were co-stimulated with either DMSO or S3I-201 for 48 hr. The pSTAT3 inhibitor robustly blocked the upregulation of IL-33 induced by IL-17A, even in the presence of influenza infection and IL-17A co-treatment ( Figure 4C ). Consistent with these transcript assays, IL-33 protein abundance was also attenuated after treatment with S3I-201 ( Figure 4D ). Thus, our results indicate that IL-17A can directly increase the production of IL-33 in lung epithelial cells downstream of STAT3 phosphorylation.
Deficiency in gd T Cells Compromises the Accumulation and Functions of ILC2s and Treg Cells
ILC2s (Monticelli et al., 2011) , Treg cells, and Th cells (Arpaia et al., 2015) have been reported to play roles in maintaining tissue homeostasis for influenza-infected adults. Each of these cell types can express the IL-33 receptor (ST2) on their cell surface and can be recruited to the lungs by IL-33. Compared to Tcrd À/À lungs, we observed more ILC2s and total Treg cells in wild-type lungs, but comparable amounts of Th cells were present in both mouse strains at day 5 after infection ( Figures 5A , 5B, and S5A). ILC2s and Treg cells have both been implicated in the production of Areg, which is important for tissue repair after influenza infection in adult mice (Arpaia et al., 2015; Monticelli et al., 2011; Zaiss et al., 2015) . The assessment of Areg levels in total wild-type lung homogenates showed that the peak of Areg production was at day 5 after infection ( Figure S5B ). Thus, we measured the amount of Areg-producing ILC2s, Treg cells, and Th cells in infected wild-type and Tcrd À/À neonates at this time point. We found higher frequencies and numbers of Aregproducing ILC2s and Treg cells in wild-type infected lungs compared to those from Tcrd-deficient mice ( Figures 5C and  5D ). In contrast, Th cell responses were equivalent between the two groups at day 5 after infection ( Figures 5D and S5C ). In addition, neutrophils accumulating in the infected lungs rarely produced Areg ( Figure S5D ). Consistent with the importance of IL-33 in regulating type 2 responses, the frequency and number of Areg-producing ILC2s were also higher in wild-type neonates compared to Il33 À/À animals ( Figures 5E and 5F ). Figure 5G ). In order to investigate the importance of Areg in the neonatal influenza model, we next assessed the levels of Areg by ELISA. The overall abundance of Areg protein was lower in Tcrd À/À whole lungs relative to wild-type lungs ( Figure 5H ), and this deficiency is likely implicated in the reduced survival rate observed in Tcrd À/À mice after infection ( Figure 1D ). Based on the kinetics of Areg production ( Figure S5B ), we also delivered Areg neutralizing antibody or isotype-control antibody intraperitoneally to wildtype mice on days 4, 6, and 9 after infection. After monitoring the survival of these treated mice, we found that Areg is protective during neonatal influenza infection ( Figure 5I ) in wild-type animals. Taken together, these results suggest that neonatal gd T cells benefit neonatal mice during influenza infection specifically by mediating Areg production via ILC2s and Treg cells. (H) Protein levels of Areg in whole-lung lysate from infected wild-type (black, n = 6) and Tcrd À/À (red, n = 6) neonates at 5 days after infection. Data are combined from two independent experiments and shown as mean ± SEM. (I) Survival rate of infected wild-type neonates that were injected intraperitoneally at days 4, 6, and 9 (shown by arrows) after influenza virus infection with Areg neutralizing antibody (purple, a-Areg antibody, 2 mg/mouse/time point, n = 21) or isotype control antibody (black, normal goat IgG control, 2 mg/mouse/time point, n = 20). Data are combined from three separate trials that individually showed the same trend. *p < 0.05, **p < 0.01, ***p < 0.001, n.s., not significant.
IL-17A, IL-33, and Areg Are Correlated with Each Other and with Improved Outcomes in Influenza-Infected Human Children
To determine whether the findings in our neonatal influenza mouse model were translatable to humans, we assessed the abundance of IL-17A, IL-33, and Areg in nasal aspirates obtained from children and infants with community-acquired influenza infection. We found that IL-33 levels were significantly and positively correlated with IL-17A levels in the airways of influenza-infected subjects ( Figure 6A ). However, IL-33 was not correlated with IFN-g ( Figure 6B ), suggesting that IL-33 production is not controlled by IFN-g in this context and that all cytokine levels were not generally correlated. We also found a positive correlation between IL-33 and Areg ( Figure 6C ). However, IFN-g and Areg ( Figure S4A ) were also correlated, possibly indicating the existence of independent pathways associated with Areg-production in human infection, or a non-mechanistic correlation between IFN-g and Areg kinetics.
In searching for correlates of disease outcome, we found that IL-17A concentrations at diagnosis (within 96 hr of symptom onset) in nasal aspirates predicted the severity of influenza illness in infants and children, as those with mild disease outcomes had significantly higher levels of IL-17A than those with severe outcomes ( Figure 6D ). In contrast, IFN-g was neither correlated with IL-17A ( Figure S4B ) nor associated with disease severity ( Figure 6E ).
To confirm our observation in mice that IL-17A can directly induce IL-33 production by lung epithelial cells, we stimulated cells from a human lung epithelial cell line (A549) with virus and/or recombinant human IL-17A together with either DMSO or the STAT3 inhibitor S3I-201 (as above). qRT-PCR analysis of these treatments indicated that, as in mice, human IL-17A can enhance the gene expression of IL33 in lung epithelial cells in a STAT3 phosphorylation-dependent manner during influenza infection ( Figures S4C) . In summary, IL-17A (rather than IFN-g) is positively associated with the IL-33-Areg axis and potentially influences the disease outcomes in children with influenza infections.
DISCUSSION
In comparison to older children and young adults, infant influenza infections are associated with higher rates of hospitalization and mortality. In the human FLU09 cohort, we previously reported that viral clearance was not impaired in infants compared to other demographic groups, and yet disease severity was increased (Oshansky et al., 2014) . Intriguingly, previous reports have also shown that neonates cannot mount robust type 1 immune responses, as revealed by the insufficient magnitude and function of neonatal CD8 + T cells (You et al., 2008) . Instead, type 2 immune responses are more dominant in the neonatal immune system (Adkins et al., 2004; Dowling and Levy, 2014; Garcia et al., 2000) , perhaps as a mechanism limiting potential inflammatory damage. As a result of the variations in the immune system evident throughout ontogeny, the parameters that determine mild or severe outcomes after influenza infection likely differ between infants and adults. During the development of the immune system, gd T cells develop and migrate to mucosal organs prior to ab T cells, (E) Concentration of IFN-g at day 0 after enrollment in the nasal aspirates of children with mild (black, n = 11) and severe (red, n = 12) disease outcomes. Data are presented as mean ± SEM, and in each case cytokine values (pg/mL) were log 10 transformed for visualization only. *p < 0.05.
suggesting that the former may play a critical role in immune competence in neonates (Chien et al., 2014; Hayday, 2000; Vantourout and Hayday, 2013) . Here, we confirmed that notion by defining a significant role for gd T cells in maintaining lung homeostasis and tissue integrity during neonatal influenza infection.
The primary function of gd T cells in this model of influenza infection appears to be the rapid production of IL-17A to initiate a cascade of type 2 and tissue repair responses, which were characterized by the induction of IL-33, the recruitment of ILC2s and Treg cells, and the production of amphiregulin. However, the ligands for gd T cell activation in this system are undetermined. This unconventional role for IL-17A diverges significantly from its better characterized contributions to type 3 immunity, for instance in responses to lung infections by bacteria such as Staphylococcus aureus (Cheng et al., 2012) and Mycobacterium tuberculosis (Lockhart et al., 2006) . Thus far, little has been discovered about the potential role of IL-17A in type 2 immunity, which predominates during allergic reactions and helminth infections rather than bacterial infections (Spellberg and Edwards, 2001) . One study has suggested that IL-17A-producing gd T cells can modulate regulatory T cell homeostasis and thermogenesis in adipose tissues by inducing IL-33 production (Kohlgruber et al., 2018) . Another study has reported an exacerbation of IL-33 production after IL-17A administration, but this was in a model of allergic asthma, where the effects of IL-17A were primarily pathological (Mizutani et al., 2014) . Although IL-17A and influenza virus both induce robust IL-33 production, IL-17A is more potent than virus in upregulating IL-33 expression in lung epithelial cells through STAT3 phosphorylation. Recent studies also found that IL-17A can promote tumor growth (Wang et al., 2009) and angiogenesis (Pan et al., 2015) via STAT3 phosphorylation, suggesting that this may be a common potential target for IL-17A signaling, with effects on tissue repair and remodeling. In contrast, canonical IL-17A signaling proceeds through the nuclear factor-kB (NF-kB) pathway mediated by ACT1 (Gaffen, 2009) , which results in the activation of the type 3 immune response traditionally associated with IL-17A. In LET1 cells we found that NF-kB activation (data not shown) was dispensable for IL-33 induction.
To confirm the specific role of IL-17A produced by gd T cells in protection, we performed a gd T cell-transfer experiment from wild-type or IL-17A-deficient mice. Our results showed a significant difference in the survival between infected Tcrd À/À neonates receiving wild-type gd T cells and those receiving Il17a À/À gd T cells. However, we also observed a delayed, but not significantly different, survival among Tcrd À/À neonates with Il17a À/À gd T cells, compared to Tcrd À/À neonates receiving a PBS control. Thus, we speculate there may be some small additional potential IL-17A-independent effects of neonatal gd T cells.
Transfer of gd T cells into mice lacking both IL-33 and gd T cells would confirm the requirement for an intact IL-33 pathway downstream of gd T cell activity and will be the subject of future experiments in the lab. Given the important role of type 2 immunity in mediating allergy and asthma, as well as the epidemiological linkages between infant infections and future development of these diseases, it seems possible that this IL-17A-IL-33 pathway may be a key link between early infection and atopy. One hypothesis for why this pathway may be more active or essential in neonates than in adults, where the effects of IL-17A appear minimal, is the significantly smaller lung volumes in the very young. Lung damage resulting from infection can, as a proportion of total lung volume, generate a greater impact on lung efficiency. Thus, robust induction of type 2 immunity and its associated tissue repair function may be necessary to maintain the capacity of the infant lung, albeit at the cost of an increased risk of subsequent pathologies.
Of particular interest, we observed that IL-17A, instead of IFN-g, is positively correlated with IL-33 in nasal aspirate samples from children with naturally acquired influenza infection. This correlation also extends to IL-33 and Areg in these samples, consistent with the findings in our mouse model demonstrating an early regulatory role of IL-17A for the subsequent immune response to neonatal influenza infection. Interestingly, this is thus far the only protective association with an increased cytokine concentration that we have observed in this cohort. In contrast, type 1 immune responses were not associated with IL-33. These data indicate that the novel IL-17A-IL-33-Areg axis may serve as a potential therapeutic target during infant influenza infection; further study of these markers across additional human cohorts will be important not only for verifying the importance of this axis in infant influenza infection, but also for fully elucidating the particular conditions underlying this aspect of gd T cell function in humans in general.
In conclusion, our findings provide evidence that IL-17A, secreted by gd T cells, has a critical function in protecting infants during influenza infection. IL-17A-producing gd T cells may provide this protection by inducing IL-33 secretion and type 2 immune responses which in turn promote tissue homeostasis and integrity.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: or rmIL-33 (3626-ML; R&D) in 10ml. For anti-Areg neutralizing experiments, wild-type neonates were infected with A/HKx31 virus in 10ml i.n. followed by intraperitoneal injection of 2ug of anti-Areg (AF989; R&D) or normal goat IgG control antibody (AB-108-C; R&D) in 50ml of PBS on days 4, 6 and 9 after infection.
For adult influenza infection, adult wild-type and Tcrd À/À littermates (8-10 weeks old) were anesthetized by Tribromoethanol (Aver-maximum/minimum set sizes) and the mouse NetPath gene set (Merico et al., 2010) . RNA-Seq data were deposited at NCBI GEO under accession GSE99683. 
Western Blotting
Proteins were extracted from stimulated cells using RIPA lysis buffer supplemented proteinase inhibitors (Roche). Samples were loaded in 12%-15% SDS-PAGE and transferred onto PVDF membranes. Blocking was performed in 5% BSA for 1 hr, and membranes were incubated in primary antibodies overnight at 4 C. Membranes were incubated with HRP-conjugated secondary antibody for 1hr, and proteins were visualized using ECL substrate (Thermo Fisher). The primary antibodies were IL-33 (1:500 dilution, AF3626, R&D), pSTAT3 (1:1,000, 9145, Cell Signaling), STAT3 (1:1,000, 9139, Cell Signaling), and b-actin (1:2,000, 8457, Cell Signaling).
Neonatal gd T cell Transfer Experiment
Neonatal gd T cells were harvested and sorted from lungs of naive wild-type and Il17a À/À neonatal littermates. Following sorting, wildtype or Il17a À/À gd T cells were resuspended in a concentration of 2x10 4 cells in 10ml of PBS and transferred to Tcrd À/À littermate mice i.n., and a third transfer treatment of plain PBS was used as a control comparison. After 24 hr, these Tcrd À/À neonates were anesthetized by isoflurane and infected i.n. with A/HKx31 in 10ml (0.6x10 3 EID 50 /g body weight). We used the log-rank test to assess survival differences as a function of treatment; after finding a significant effect, we then tested for pairwise differences between: 1) neonates receiving wild-type and Il17a À/À cells, and 2) between neonates receiving wild-type cells and PBS. We verified that there were no effects of experimental batch on survival by independently testing for effects of experiment number.
Single-cell Sorting and Multiplex PCR Single cell suspension was made from wild-type lungs with mock-or influenza-(day 2 or 6) infections and stained with a live/dead exclusion dye (Live/dead aqua, Tonbo Biosciences), APC-conjugated anti-mouse CD3 (clone: 17A2) and PE-conjugated anti-mouse gdTCR (clone: GL3). The stained cells were resuspended in RNase inhibitor containing sort buffer (RNAsin, Promega, 200U/ml) and sorted by gating on gdTCR + CD3 + cells directly into a 384-well PCR plate that had been preloaded with 1ml of reverse transcription reaction mix [1X SuperScript VILO Reaction Mix (Thermo Fisher), SuperScript VILO enzyme and 1X0.1% NP40 (Thermo Fisher)] with a sorter (Model SY3200, Sony Biotech Synergy sorter, Sony Biotech, San Jose, CA). The last column of the plate was left empty for use as PCR negative controls. After sorting, plates were, sealed and kept on ice until the sort is over, briefly centrifuged at 500 g and stored at À80 C until downstream processing. Following single-cell sort into a 384 well PCR plate, direct lysis and reverse transcription was performed using SuperScript Vilo (Invitrogen) as described before (Guo et al., 2016) . The resultant cDNA was subjected to a first round PCR reaction using a cocktail of TCRVg region-specific forward and C region-specific reverse primers (Table S1 ). Using a corresponding internal primer pool, the first round PCR products were further subjected to a nested PCR. The PCR products were purified by Exonuclease I/Shrimp Alkaline Phosphatase treatment (Dash et al., 2015) and sequenced as described with a TRGC internal primer using an ABI Big Dye sequencer (Applied Biosystems) at the Hartwell Center, St. Jude Children's Research Hospital. The sequence data were analyzed using a custom-built macro-enabled Microsoft Excel sheet to derive CDR3 nucleotide and amino acid sequences (available upon request). To determine the corresponding TRGV-TRGJ usage, the sequence data derived from single cells were matched against the IMGT database ( Lefranc et al., 2009 ).
Human Samples and Cytokine Measurement
To characterize human cytokines during influenza infection, we utilized nasal lavages obtained as part of the FLU09 study (Oshansky et al., 2014) . FLU09 participants provided lavages at varying intervals from the day of enrollment through 12 days after enrollment. For this study, we focused on samples from a subset of infants and children below the age of 8 years (n = 25) who were verifiably infected with influenza A (pH1 or H3). Cells were separated from cell-free/mucus-free supernatants, and samples were stored at À80 C until analysis. Cytokines were measured in supernatants as follows: IL-17A, IL-33, and amphiregulin were assayed by Human IL-17A, IL-33, and amphiregulin DuoSet ELISA kits (R&D), and the level of IFN-g was detected by Human Milliplex assays (Millipore) according to manufacturer instructions. To determine severity of influenza disease outcome, patients who were admitted to an emergency room or hospital were considered ''severe'' cases, whereas all other participants were considered ''mild'' cases.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were analyzed with Prism 7.0 software (GraphPad) and presented as mean ± SEM unless otherwise indicated. Experiments were repeated at least twice, as indicated. Statistical significance was determined by Mann-Whitney test between two groups. For comparison across three or more groups, non-parametric one-way ANOVA (Kruskal-Wallis test) was used, and differences between individual groups were estimated using Dunn's multiple comparisons test. For the comparison of two groups at different time points, two-way ANOVA was used, and differences between individual groups were estimated using Sidak's multiple comparisons test. To compare relative weight gain between wild-type and Tcrd À/À neonates from 1-15 days after infection, we used a linear mixedeffects model via the ''lmer'' function in the R package lme4 (v1.1-13) (Bates et al., 2015) and assessed the significance of effects with Wald tests; specifically, genotype was modeled as a function of relative weight gain, with mixed effects allowing intercepts to vary across subjects (in order to control for individual differences among the repeatedly measured mice) and allowing the effect of genotype to vary across time points. The difference of survival rate was determined using the log-rank test. p < 0.05 was considered statistically significant where *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and n.s., non significant. For the repertoire analysis, because chi-square tests were not applicable due to the presence of zero-values in contingency table cells, statistical association across treatment conditions was assessed using Fisher's exact test as implemented in R (Clarkson et al., 1993) . Overall comparisons across days-post-infection for a given cell type (i.e., CD27 + or CD27 -) were constructed as 3x7 contingency tables representing 3 treatment conditions and 7 possible gene segments. In the case that this overall comparison was significant, the simple effects were resolved by constructing 2x7 contingency tables for each pairwise comparison. P values were adjusted to control family-wise error rate using Holm's method (Holm, 1979) .
For human cytokine analyses, we initially focused on the putative correlations underlying the proposed IL-17A/IL-33/Areg axis, using generalized linear mixed models with a log-link of the Gaussian distribution, as implemented by the R package MASS (v7.3-47) (Venables and Ripley, 2002) , to investigate correlations among the adjacent components of the axis (i.e., IL-33 as a function of IL-17A, and Areg as a function of IL-33). In each case, we also included age, study day, and IFN-g expression as fixed effects, and patient-ID was included as a random effect in order to account for repeated sampling within patients over the course of the study. We also analyzed IFN-g expression as a function of axis cytokines, using both the Gamma and Gaussian distributions. To investigate potential correlations between cytokine levels and disease severity, we focused on samples collected on the day at which disease severity was assessed (i.e., study day 0); for these analyses, we used the natural logarithm transformation to obtain normally distributed cytokine measures and ages, and we employed multifactor Analysis of Variance models (R aov function), with age included as a covariate. For significant effects in aov models, we confirmed equal variances between groups using an F-test (R var.test function).
DATA AND SOFTWARE AVAILABILITY
The RNA-seq data from whole lung RNA of wild-type and Tcrd À/À neonates (day 8 after infection) has been deposited in the Gene Expression Omnibus (GEO, NCBI) under accession code GEO: GSE99683.
